The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

On a jour­ney to dras­ti­cal­ly speed up cell ther­a­py man­u­fac­tur­ing, Ky­topen lands $30M Se­ries A

4 years ago
Financing
Startups

Till­man Gern­gross project out of Dart­mouth Col­lege ac­quired by Repli­gen

4 years ago
Deals

Lon­za un­veils new ex­pan­sion plans at Swiss man­u­fac­tur­ing sites, cap­ping off a very busy pan­dem­ic

4 years ago

Take­da breaks ground on ze­ro-emis­sion site in Asia; Boston Labs emerges from stealth with mo­bile cell, gene ther­a­py tech

4 years ago

Catal­ent inks deal with Phath­om to make GI drug at re­cent­ly-ren­o­vat­ed Ken­tucky site

4 years ago
Outsourcing

Re­call re­port: Pfiz­er pulls even more Chan­tix lots as ni­trosamine con­t­a­m­i­na­tion wor­ries grow

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Bharat Biotech turns to oth­er pro­duc­ers to up sup­ply; Brazil, Ar­genti­na land mR­NA re­gion­al hubs

4 years ago
Coronavirus

Ver­ri­ca hits an­oth­er bump in the road with CMO re­lat­ed let­ter from FDA

4 years ago
FDA+

With plans to spend $360M, As­traZeneca will build its first-ever man­u­fac­tur­ing site in Ire­land

4 years ago

AGC un­veils Ger­man ex­pan­sion plans as gene and cell ther­a­py man­u­fac­tur­ing com­pe­ti­tion heats up

4 years ago

DNA play­er Touch­light dou­bles fundrais­ing this year with lat­est round of pri­vate back­ers on board

4 years ago

Emer­gent gets a chance to re­deem it­self in mR­NA vac­cine deal with Prov­i­dence Ther­a­peu­tics

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Kenya will add man­u­fac­tur­ing plant, up vac­ci­na­tion sites; South Ko­rea left wait­ing on Rus­sia vac­cine ex­ports

4 years ago
Coronavirus

NeuEx­cell strikes deal with Fu­ji­film for stroke gene ther­a­py; J&J ex­pands in Ire­land

4 years ago

Re­call re­port: Chil­dren's au­to-im­mune dis­ease drug con­t­a­m­i­nat­ed with mold and yeast

4 years ago

As­traZeneca amends li­cense deal with Chi­nese biotech; Chi­nese pro­tein-based vac­cine gets man­u­fac­tur­ing OK

4 years ago

Vec­tor Labs de­cou­ples from Mar­a­vai, pop­ping up shop with pri­vate cap­i­tal, new CEO on board

4 years ago

Re­cro takes on big broth­er role with opi­oid ad­dic­tion drug mak­er, han­dling man­u­fac­tur­ing du­ties and ad­vis­ing on FDA work

4 years ago

Ther­mo Fish­er, as part of glob­al ex­pan­sion plans, out­lines new sin­gle-use site in Nashville

4 years ago

Covid-19 man­u­fac­tur­ing roundup: Rus­sia will pro­duce Sput­nik V in Pe­ru — re­port; CEPI calls for es­tab­lished vac­cine use in tri­als

4 years ago

Re­call re­port: Amino acid IV pulled af­ter hair, oth­er for­eign sub­stances found in batch

4 years ago

Months af­ter land­ing Cana­di­an site from gov­ern­ment, Re­silience an­nounces a big mR­NA part­ner

4 years ago
Deals

With in­dus­try's bless­ing, FDA launch­es nov­el ex­cip­i­ent re­view pi­lot pro­gram

4 years ago
FDA+

Dou­bling down on need for mR­NA vac­cines and mAbs, Avan­tor puts near­ly $3B in pumps and tub­ing com­pa­ny

4 years ago
First page Previous page 65666768697071 Next page Last page
A service from the Financial Times